Home   >  
Angiogenesis/Protein Tyrosine Kinase

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Gusacitinib HCl Chemical Structure
BCP31676 Gusacitinib HCl GusacitinibHCl
Gusacitinib (ASN-002) is a potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 values of 5-46 nM.
Gusacitinib Chemical Structure
BCP31675 Gusacitinib 1425381-60-7
Gusacitinib (ASN-002) is a potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 values of 5-46 nM.
Lanraplenib Chemical Structure
BCP30292 Lanraplenib 1800046-95-0
GS-9876 is a novel, highly selective, SYK Inhibitor.
R 112 Chemical Structure
BCP20695 R 112 575474-82-7
R112 is an ATP-competitive inhibitor of Syk kinase with a Ki of 96 nM. R112 inhibits Syk kinase activity with an IC50 of 226 nM.
RO 9021 Chemical Structure
BCP17963 RO 9021 1446790-62-0
RO9021 is an oral, ATP-competative and selective inhibitor of spleen tyrosine kinase (SYK). RO-9021 potently inhibited SYK kinase activity with an average IC50 of 5.6 nM.
PRT-060318 Chemical Structure
BCP13151 PRT-060318 1194961-19-7
PRT-060318 (PRT318,P142–76) is a novel selective inhibitor of the tyrosine kinase Syk with an IC50 of 4 nM.
BAY 61-3606 dihydrochloride Chemical Structure
BCP24726 BAY 61-3606 dihydrochloride 648903-57-5
AY 61-3606 (dihydrochloride) is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase (IC50=10 nM) with no inhibitory effect on Btk, Fyn, Itk, Lyn, and Src.
Cerdulatinib HCl salt Chemical Structure
BCP25893 Cerdulatinib HCl salt 1369761-01-2
Cerdulatinib is a novel, orally available, ATP-competitive JAK and SYK inhibitor that demonstrates selective inhibition of TYK2 and SYK with an IC50 of 0.5 nM and 32 nM.
PRT062607 HCl Chemical Structure
BCP09980 PRT062607 HCl 1370261-97-4
PRT062607 Hcl is a novel, highly selective, and orally bioavailable small molecule SYK inhibitor (SYK IC(50) = 1 nM) with anti-SYK activity that is at least 80-fold greater than its affinity for other kinases.
 TAK-659 2HCl  Chemical Structure
BCP28885 TAK-659 2HCl 1312691-41-0
TAK-659 is a potent spleen tyrosine kinase (syk) inhibitor under the development of Takeda Oncology, with potential anti-inflammatory, immunomodulating, and antineoplastic activities.
123下一页共 21 条记录 1 / 3 页